Bioqual, Inc. (BIOQ)
Runs labs testing experimental drugs and vaccines for disease research.
$32.50+0.00%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-24.8%
The outlook
BIOQ is trading near its 52-week low with the price sitting below both its 50- and 200-day moving averages, signaling a downtrend. Analyst coverage appears limited, and the stock carries a bearish sentiment score. At a trailing P/E of 15.9, valuation is moderate, though the technical positioning suggests weakness in the near term.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range0% of the way from its 52-week low to high
Market cap
$29.1M
52-wk high
$43.55
52-wk low
$32.50
50-day avg
$32.96
200-day avg
$36.85
Trailing P/E
15.9